Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Bevacizumab × Myeloid × 30 days × Clear all

Sponsor

Cancer Type

Gastrointestinal 48 Gynecologic 25 Thoracic 14 CNS 9 Other solid neoplasm 8 Breast 6 Head & Neck 5 Genitourinary 3 Endocrine 2 Dermatologic 2 Tumor-Agnostic 1 Sarcoma 1 NET 1

Interventions

Azacitidine 20 venetoclax 18 fludarabine 16 Specimen Handling 16 Biopsy 15 Cyclophosphamide 14 fludarabine phosphate 12 Whole-Body Irradiation 9 Busulfan 9 decitabine and cedazuridine drug combination 8 Mycophenolic Acid 8 Injections 8 Stem Cell Transplantation 7 Melphalan 7 Granulocyte Colony-Stimulating Factor 7 Decitabine 7 Cytarabine 7 ruxolitinib 5 X-Rays 5 Tacrolimus 5 Filgrastim 5 Thiotepa 4 Mesna 4 Magnetic Resonance Spectroscopy 4 Cyclosporins 4 Cyclosporine 4 Blood Specimen Collection 4 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 4 olutasidenib 3 asciminib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡